Home2162 • HKG
add
Keymed Biosciences Inc
Previous close
$42.10
Day range
$41.20 - $42.60
Year range
$26.60 - $56.55
Market cap
11.75B HKD
Avg Volume
1.24M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 27.34M | -83.28% |
Operating expense | 222.20M | 33.65% |
Net income | -168.37M | -816.98% |
Net profit margin | -615.82 | -4,388.44% |
Earnings per share | — | — |
EBITDA | -177.90M | -18,577.01% |
Effective tax rate | -1.84% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.58B | -13.50% |
Total assets | 3.81B | -6.45% |
Total liabilities | 1.17B | 68.48% |
Total equity | 2.64B | — |
Shares outstanding | 275.60M | — |
Price to book | 4.40 | — |
Return on assets | -12.92% | — |
Return on capital | -14.51% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -168.37M | -816.98% |
Cash from operations | -182.96M | -1,023.06% |
Cash from investing | -19.93M | -108.97% |
Cash from financing | 131.96M | 6,820.75% |
Net change in cash | -70.56M | -127.61% |
Free cash flow | -148.22M | -31.18% |
About
CEO
Founded
Sep 2016
Website
Employees
1,116
